Acellular and cellular approaches to improve diabetic wound healing

Hongkwan Cho, Michael R. Blatchley, Elia J Duh, Sharon Gerecht

Research output: Contribution to journalArticle

Abstract

Chronic diabetic wounds represent a huge socioeconomic burden for both affected individuals and the entire healthcare system. Although the number of available treatment options as well as our understanding of wound healing mechanisms associated with diabetes has vastly improved over the past decades, there still remains a great need for additional therapeutic options. Tissue engineering and regenerative medicine approaches provide great advantages over conventional treatment options, which are mainly aimed at wound closure rather than addressing the underlying pathophysiology of diabetic wounds. Recent advances in biomaterials and stem cell research presented in this review provide novel ways to tackle different molecular and cellular culprits responsible for chronic and nonhealing wounds by delivering therapeutic agents in direct or indirect ways. Careful integration of different approaches presented in the current article could lead to the development of new therapeutic platforms that can address multiple pathophysiologic abnormalities and facilitate wound healing in patients with diabetes.

Original languageEnglish (US)
JournalAdvanced Drug Delivery Reviews
DOIs
StateAccepted/In press - Jan 1 2018

Fingerprint

Wound Healing
Wounds and Injuries
Multiple Abnormalities
Therapeutics
Stem Cell Research
Regenerative Medicine
Biocompatible Materials
Tissue Engineering
Delivery of Health Care

Keywords

  • Cell therapy
  • Diabetic wound healing
  • Scaffolds
  • Tissue engineering

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this

Acellular and cellular approaches to improve diabetic wound healing. / Cho, Hongkwan; Blatchley, Michael R.; Duh, Elia J; Gerecht, Sharon.

In: Advanced Drug Delivery Reviews, 01.01.2018.

Research output: Contribution to journalArticle

@article{ef387ac6050940828035028ecb0a5826,
title = "Acellular and cellular approaches to improve diabetic wound healing",
abstract = "Chronic diabetic wounds represent a huge socioeconomic burden for both affected individuals and the entire healthcare system. Although the number of available treatment options as well as our understanding of wound healing mechanisms associated with diabetes has vastly improved over the past decades, there still remains a great need for additional therapeutic options. Tissue engineering and regenerative medicine approaches provide great advantages over conventional treatment options, which are mainly aimed at wound closure rather than addressing the underlying pathophysiology of diabetic wounds. Recent advances in biomaterials and stem cell research presented in this review provide novel ways to tackle different molecular and cellular culprits responsible for chronic and nonhealing wounds by delivering therapeutic agents in direct or indirect ways. Careful integration of different approaches presented in the current article could lead to the development of new therapeutic platforms that can address multiple pathophysiologic abnormalities and facilitate wound healing in patients with diabetes.",
keywords = "Cell therapy, Diabetic wound healing, Scaffolds, Tissue engineering",
author = "Hongkwan Cho and Blatchley, {Michael R.} and Duh, {Elia J} and Sharon Gerecht",
year = "2018",
month = "1",
day = "1",
doi = "10.1016/j.addr.2018.07.019",
language = "English (US)",
journal = "Advanced Drug Delivery Reviews",
issn = "0169-409X",
publisher = "Elsevier",

}

TY - JOUR

T1 - Acellular and cellular approaches to improve diabetic wound healing

AU - Cho, Hongkwan

AU - Blatchley, Michael R.

AU - Duh, Elia J

AU - Gerecht, Sharon

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Chronic diabetic wounds represent a huge socioeconomic burden for both affected individuals and the entire healthcare system. Although the number of available treatment options as well as our understanding of wound healing mechanisms associated with diabetes has vastly improved over the past decades, there still remains a great need for additional therapeutic options. Tissue engineering and regenerative medicine approaches provide great advantages over conventional treatment options, which are mainly aimed at wound closure rather than addressing the underlying pathophysiology of diabetic wounds. Recent advances in biomaterials and stem cell research presented in this review provide novel ways to tackle different molecular and cellular culprits responsible for chronic and nonhealing wounds by delivering therapeutic agents in direct or indirect ways. Careful integration of different approaches presented in the current article could lead to the development of new therapeutic platforms that can address multiple pathophysiologic abnormalities and facilitate wound healing in patients with diabetes.

AB - Chronic diabetic wounds represent a huge socioeconomic burden for both affected individuals and the entire healthcare system. Although the number of available treatment options as well as our understanding of wound healing mechanisms associated with diabetes has vastly improved over the past decades, there still remains a great need for additional therapeutic options. Tissue engineering and regenerative medicine approaches provide great advantages over conventional treatment options, which are mainly aimed at wound closure rather than addressing the underlying pathophysiology of diabetic wounds. Recent advances in biomaterials and stem cell research presented in this review provide novel ways to tackle different molecular and cellular culprits responsible for chronic and nonhealing wounds by delivering therapeutic agents in direct or indirect ways. Careful integration of different approaches presented in the current article could lead to the development of new therapeutic platforms that can address multiple pathophysiologic abnormalities and facilitate wound healing in patients with diabetes.

KW - Cell therapy

KW - Diabetic wound healing

KW - Scaffolds

KW - Tissue engineering

UR - http://www.scopus.com/inward/record.url?scp=85051066523&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85051066523&partnerID=8YFLogxK

U2 - 10.1016/j.addr.2018.07.019

DO - 10.1016/j.addr.2018.07.019

M3 - Article

C2 - 30075168

AN - SCOPUS:85051066523

JO - Advanced Drug Delivery Reviews

JF - Advanced Drug Delivery Reviews

SN - 0169-409X

ER -